Safety and therapeutic efficacy of 225Ac-DOTATATE targeted alpha therapy in metastatic gastroenteropancreatic neuroendocrine tumors stable or refractory to 177Lu-DOTATATE PRRT

Authors
Category Primary study
JournalJournal of Nuclear Medicine
Year 2020
This article has no abstract
Epistemonikos ID: 8390af68a05c3fcb8aaa015277b0993ebc928382
First added on: Feb 12, 2025